Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Davies

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2025
MITD1 is a brain-specific interferon-inducible factor that inhibits flavivirus replicationJim Zoladek, Marion Cannac, Maël Seite, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 25, 2019
Trajectories of depression symptom change during and following treatment in adolescents with unipolar major depressionSian Emma Davies, Sharon A S Neufeld, Eleonore van Sprang, et al.
Oncotarget|May 19, 2018
Selumetinib-based therapy in uveal melanoma patient-derived xenograftsDidier Decaudin, Rania El Botty, Béré Diallo, et al.
Journal of Clinical Microbiology|September 26, 2024
A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infectionsBenjamin Berinson, Emma Davies, Jessie Torpner, et al.
EMBO Molecular Medicine|May 19, 2020
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcomaHenry G Smith, Kunzah Jamal, Jasbani Hs Dayal, et al.
Journal of Parkinson'S Disease|February 20, 2025
Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping reviewRebecca Petty, Veena Agarwal, Jennifer Allison, et al.
Open Forum Infectious Diseases|April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial CohortEmma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Nature Communications|January 24, 2020
The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatusTakanori Furukawa, Norman van Rhijn, Marcin Fraczek, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Journal of Medicinal Chemistry|April 5, 2017
Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start PointRichard A Ward, Paul Bethel, Calum Cook, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2025
MITD1 is a brain-specific interferon-inducible factor that inhibits flavivirus replicationJim Zoladek, Marion Cannac, Maël Seite, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|October 25, 2019
Trajectories of depression symptom change during and following treatment in adolescents with unipolar major depressionSian Emma Davies, Sharon A S Neufeld, Eleonore van Sprang, et al.
Oncotarget|May 19, 2018
Selumetinib-based therapy in uveal melanoma patient-derived xenograftsDidier Decaudin, Rania El Botty, Béré Diallo, et al.
Journal of Clinical Microbiology|September 26, 2024
A multicenter evaluation of a novel microfluidic rapid AST assay for Gram-negative bloodstream infectionsBenjamin Berinson, Emma Davies, Jessie Torpner, et al.
EMBO Molecular Medicine|May 19, 2020
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcomaHenry G Smith, Kunzah Jamal, Jasbani Hs Dayal, et al.
Journal of Parkinson'S Disease|February 20, 2025
Improving recruitment and retention of people with Parkinson's disease to clinical studies: A scoping reviewRebecca Petty, Veena Agarwal, Jennifer Allison, et al.
Open Forum Infectious Diseases|April 10, 2025
Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial CohortEmma Davies Smith, Carlos Malvestutto, Heather J Ribaudo, et al.
Nature Communications|January 24, 2020
The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatusTakanori Furukawa, Norman van Rhijn, Marcin Fraczek, et al.
The Lancet. HIV|June 7, 2025
Effects of antiretrovirals on major adverse cardiovascular events in the REPRIEVE trial: a longitudinal cohort analysisCarl J Fichtenbaum, Carlos D Malvestutto, Maya G Watanabe, et al.
Journal of Medicinal Chemistry|April 5, 2017
Structure-Guided Discovery of Potent and Selective Inhibitors of ERK1/2 from a Modestly Active and Promiscuous Chemical Start PointRichard A Ward, Paul Bethel, Calum Cook, et al.
Pageof 14